CELLID, CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,045 KRW | +0.74% |
|
-14.44% | -54.25% |
| 2023 | Cellid, Co., Ltd.(KOSDAQ:A299660) dropped from S&P Global BMI Index | CI |
| 2021 | Private S.Korea firms plan $5.4 billion investment to create vaccine hub | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLID, CO., LTD. | Bio Therapeutic Drugs | +0.74% | -14.44% | -54.25% | -69.75% | -93.06% | 20.19M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A299660 Stock
- Charts Cellid, Co., Ltd.
- Comparison Chart
